Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Identification of Urine Organic Acids for the Detection of Inborn Errors of Metabolism Using Urease and Gas Chromatography-Mass Spectrometry (GC/MS).
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 20, 2022
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients.
Journal: Molecular genetics and metabolism
Published: May 01, 2019
Characteristic Pulvinar Sign in Pseudo-α-galactosidase Deficiency Syndrome.
Journal: JAMA neurology
Published: June 21, 2016
Glutamine and hyperammonemic crises in patients with urea cycle disorders.
Journal: Molecular genetics and metabolism
Published: September 21, 2015
Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Journal: Molecular genetics and metabolism
Published: August 02, 2015
Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase.
Journal: Molecular genetics and metabolism
Published: March 10, 2015
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.
Journal: American journal of medical genetics. Part A
Published: November 10, 2014
Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 13, 2014
Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
Journal: Molecular genetics and metabolism
Published: January 14, 2014
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.
Journal: Molecular genetics and metabolism
Published: September 26, 2013
Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
Journal: Clinical genetics
Published: May 23, 2013
Last Updated: 09/26/2026